Cargando…

NAD pool as an antitumor target against cancer stem cells in head and neck cancer

Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous group of tumors that affect different anatomical locations. Despite this heterogeneity, HNSCC treatment depends on the anatomical location, TNM stage and resectability of the tumor. Classical chemotherapy is based on platinum-derived d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navas, Lola E., Blanco-Alcaina, Elena, Suarez-Martinez, Elisa, Verdugo-Sivianes, Eva M., Espinosa-Sanchez, Asuncion, Sanchez-Diaz, Laura, Dominguez-Medina, Eduardo, Fernandez-Rozadilla, Ceres, Carracedo, Angel, Wu, Lindsay E., Carnero, Amancio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983242/ https://www.ncbi.nlm.nih.gov/pubmed/36864434 http://dx.doi.org/10.1186/s13046-023-02631-2

Ejemplares similares

NAD(+) metabolism, stemness, the immune response, and cancer
por: Navas, Lola E., et al.
Publicado: (2021)

Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer
por: Navas, Lola E., et al.
Publicado: (2022)

Tumor Profiling at the Service of Cancer Therapy
por: Fernandez-Rozadilla, Ceres, et al.
Publicado: (2021)

NAMPT as a Dedifferentiation-Inducer Gene: NAD(+) as Core Axis for Glioma Cancer Stem-Like Cells Maintenance
por: Lucena-Cacace, Antonio, et al.
Publicado: (2019)

Chronotherapy: Circadian Rhythms and Their Influence in Cancer Therapy
por: Amiama-Roig, Ana, et al.
Publicado: (2022)

Role of the Holoenzyme PP1-SPN in the Dephosphorylation of the RB Family of Tumor Suppressors During Cell Cycle
por: Verdugo-Sivianes, Eva M., et al.
Publicado: (2021)

c‐MYB‐ and PGC1a‐dependent metabolic switch induced by MYBBP1A loss in renal cancer
por: Felipe‐Abrio, Blanca, et al.
Publicado: (2019)

Senotherapeutics in Cancer and HIV
por: Sánchez-Díaz, Laura, et al.
Publicado: (2022)

Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer
por: Felipe-Abrio, Blanca, et al.
Publicado: (2019)

New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools
por: Muñoz-Galván, Sandra, et al.
Publicado: (2019)

Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness
por: Espinosa-Sánchez, Asunción, et al.
Publicado: (2020)

Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy
por: García-Heredia, José M., et al.
Publicado: (2016)

The Road so Far in Colorectal Cancer Pharmacogenomics: Are We Closer to Individualised Treatment?
por: Simões, Ana Rita, et al.
Publicado: (2020)

Mutation of SPINOPHILIN (PPP1R9B) found in human tumors promotes the tumorigenic and stemness properties of cells
por: Verdugo-Sivianes, Eva M, et al.
Publicado: (2021)

Liquid Biopsy Biomarkers for Immunotherapy in Non-Small Cell Lung Carcinoma: Lessons Learned and the Road Ahead
por: Hita-Millan, Jesus, et al.
Publicado: (2021)

Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer
por: Verdugo-Sivianes, Eva M., et al.
Publicado: (2017)

A Six-Gene Prognostic and Predictive Radiotherapy-Based Signature for Early and Locally Advanced Stages in Non-Small-Cell Lung Cancer
por: Peinado-Serrano, Javier, et al.
Publicado: (2022)

Implications of maraviroc and/or rapamycin in a mouse model of fragility
por: Pérez-Martínez, Laura, et al.
Publicado: (2020)

Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

A new treatment for sarcoma extracted from combination of miRNA deregulation and gene association rules
por: García-Heredia, José Manuel, et al.
Publicado: (2023)

High casein kinase 1 epsilon levels are correlated with better prognosis in subsets of patients with breast cancer
por: Lopez-Guerra, Jose Luis, et al.
Publicado: (2015)

Patterns of genetic differentiation and the footprints of historical migrations in the Iberian Peninsula
por: Bycroft, Clare, et al.
Publicado: (2019)

MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy
por: Rivero, Maria, et al.
Publicado: (2018)

Should We Expect an Increase in the Number of Cancer Cases in People with Long COVID?
por: Amiama-Roig, Ana, et al.
Publicado: (2023)

Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

3D and organoid culture in research: physiology, hereditary genetic diseases and cancer
por: Suarez-Martinez, Elisa, et al.
Publicado: (2022)

Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma
por: Garcia-Mayea, Yoelsis, et al.
Publicado: (2022)

Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2021)

Role of Mitochondria in Cancer Stem Cell Resistance
por: García-Heredia, José Manuel, et al.
Publicado: (2020)

The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models
por: Carnero, Amancio, et al.
Publicado: (2014)

Molecular Radiobiology in Non-Small Cell Lung Cancer: Prognostic and Predictive Response Factors
por: Peinado-Serrano, Javier, et al.
Publicado: (2022)

Role of PGC-1α in the Mitochondrial NAD(+) Pool in Metabolic Diseases
por: Koh, Jin-Ho, et al.
Publicado: (2021)

Pharmacogenomics of CRC treatments: putting bricks on the path to personalized medicine
por: Fernández-Rozadilla, Ceres, et al.
Publicado: (2014)

Dr. Jekyll and Mr. Hyde: MAP17’s up-regulation, a crosspoint in cancer and inflammatory diseases
por: García-Heredia, José M., et al.
Publicado: (2018)

Single Nucleotide Polymorphisms in the Wnt and BMP Pathways and Colorectal Cancer Risk in a Spanish Cohort
por: Fernández-Rozadilla, Ceres, et al.
Publicado: (2010)

Cellular Senescence as a Target in Cancer Control
por: Vergel, Mar, et al.
Publicado: (2010)

MAP17, a ROS-dependent oncogene
por: Carnero, Amancio
Publicado: (2012)

NAD Metabolism in Cancer Therapeutics
por: Yaku, Keisuke, et al.
Publicado: (2018)

Cancer, Senescence, and Aging: Translation from Basic Research to Clinics
por: LLeonart, Matilde E., et al.
Publicado: (2011)

Large dependency of intracellular NAD and CoA pools on cultivation conditions in Saccharomyces cerevisiae
por: Kumar, Kanhaiya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_54vnojbmiqlulj6gpk5ugjrvgb